Defense Equipment/Products

Novartis to bolster its oncology portfolio with acquisition of MorphoSys

It’s shaping as much as be an awesome quarter for Europe’s largest firms — no because of Europe.

Medicare drug-price negotiations are on: Seniors may quickly get an enormous break on drug costs

Northrop Grumman enters $1 billion accelerated buyback cope with Morgan Stanley

Sell AstraZeneca, says UBS, which upgrades European rivals together with GSK

GSK to purchase bronchial asthma drug developer for as much as $1.4 billion in pipeline push

Boeing and Lockheed’s ULA launches first Vulcan rocket, non-public moon lander

Boeing, Lockheed Martin’s United Launch Alliance to launch first Vulcan rocket

GSI Technology clinches AI-chip cope with U.S. Air Force

Oil costs rise as Iran sends warship to Red Sea after U.S. destroys Houthi vessels